Publications by authors named "Eleni Arvanitou"
Key Clinical Message: There is no consensus regarding the therapeutic approach of breast neuroendocrine carcinomas (NECs). As most NECs are hormone receptor positive and HER-2 negative, we suggest that endocrine-based strategies may play a leading role. Here, we report a new treatment strategy by incorporating CDK4/6 inhibitors in the therapeutic armamentarium.
View Article and Find Full Text PDFExploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study.
Curr Oncol
August 2023
Article Synopsis
- - The study aimed to evaluate the feasibility of the CureCancer platform for Greek cancer patients, focusing on their ability to register and report various personal and health-related information amid increasing cancer care complexity due to new treatments and the COVID-19 pandemic.
- - Out of 159 invited patients, 144 registered (90.56%), and 114 completed the questionnaire (79.16%), indicating a strong interest and ease of use among participants; most were educated individuals with a median age of 54.5 years.
- - The demographics revealed that a significant portion had breast and lung cancers, with many undergoing active therapy, highlighting the diverse cancer experiences and reporting trends of those participating in the study.
Objective: Anxiety and depression are common in cancer patients and seem to affect quality of life, treatment compliance and even survival. Defining factors related to anxiety and depression and exploring the role of demoralization and satisfaction with care, could contribute to the improvement of patients' quality of life and quality of health services as well.
Methods: A convenience sample of 150 cancer inpatients and outpatients from two oncology centers, with various types of solid tumors, participated in a prospective cross-sectional observational study.
Sinonasal tumors arising from Schneiderian papillomas, most frequently associated with squamous cell carcinoma (SCC), are rare and often present with non-specific symptoms, even in an advanced stage. Herein, we report the case of a 61-year-old male who presented with a four-month history of progressive binocular diplopia, blepharoptosis, and amblyopia, and upon the essential diagnostic work-up he was subsequently diagnosed with SCC arising from an SP. Surgical management was not warranted due to the extent of the disease, so induction chemotherapy with cisplatin and 5-fluorouracil (5-FU) was commenced, followed by definitive concurrent chemoradiotherapy (CRT).
View Article and Find Full Text PDF